nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—vagina—cervical cancer	0.0765	0.2	CbGeAlD
Amrinone—TNF—lymph node—cervical cancer	0.0495	0.129	CbGeAlD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0324	0.0525	CbGpPWpGaD
Amrinone—PDE3A—female reproductive system—cervical cancer	0.03	0.0785	CbGeAlD
Amrinone—PDE4B—uterine cervix—cervical cancer	0.0289	0.0755	CbGeAlD
Amrinone—PDE4B—decidua—cervical cancer	0.0275	0.072	CbGeAlD
Amrinone—PDE3A—female gonad—cervical cancer	0.0273	0.0714	CbGeAlD
Amrinone—PDE4B—endometrium—cervical cancer	0.0261	0.0683	CbGeAlD
Amrinone—PDE4B—mammalian vulva—cervical cancer	0.0252	0.0661	CbGeAlD
Amrinone—PDE3A—G alpha (s) signalling events—TAAR6—cervical cancer	0.0252	0.0407	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—TAAR6—cervical cancer	0.0239	0.0387	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—YY1—cervical cancer	0.0234	0.0379	CbGpPWpGaD
Amrinone—PDE4B—female reproductive system—cervical cancer	0.0216	0.0566	CbGeAlD
Amrinone—PDE4B—G Protein Signaling Pathways—AKAP13—cervical cancer	0.0206	0.0334	CbGpPWpGaD
Amrinone—TNF—Death Receptor Signalling—CASP8—cervical cancer	0.0199	0.0322	CbGpPWpGaD
Amrinone—PDE4B—female gonad—cervical cancer	0.0197	0.0515	CbGeAlD
Amrinone—PDE4B—vagina—cervical cancer	0.0196	0.0512	CbGeAlD
Amrinone—PDE3A—lymph node—cervical cancer	0.0175	0.0459	CbGeAlD
Amrinone—PDE4B—lymph node—cervical cancer	0.0126	0.0331	CbGeAlD
Amrinone—PDE3A—Hemostasis—SERPIND1—cervical cancer	0.0123	0.02	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—GP6—cervical cancer	0.0123	0.02	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—WNT5A—cervical cancer	0.012	0.0194	CbGpPWpGaD
Amrinone—TNF—Type II diabetes mellitus—MTOR—cervical cancer	0.0114	0.0184	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.0112	0.0181	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—GP5—cervical cancer	0.0108	0.0174	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP8—cervical cancer	0.01	0.0162	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—HLA-DPB1—cervical cancer	0.00977	0.0158	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—CD4—cervical cancer	0.00965	0.0156	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—INSM1—cervical cancer	0.00909	0.0147	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.00903	0.0146	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—CASP8—cervical cancer	0.00825	0.0134	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—CASP8—cervical cancer	0.00825	0.0134	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—cervical cancer	0.00822	0.0133	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—STAT3—cervical cancer	0.0077	0.0125	CbGpPWpGaD
Amrinone—TNF—TNF receptor signaling pathway —CASP8—cervical cancer	0.00767	0.0124	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—HLA-DQB1—cervical cancer	0.00762	0.0123	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—cervical cancer	0.00757	0.0123	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—CD4—cervical cancer	0.0075	0.0121	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—CASP8—cervical cancer	0.00742	0.012	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—MTHFR—cervical cancer	0.00735	0.0119	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—CASP3—cervical cancer	0.00677	0.0109	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00658	0.0106	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—CASP8—cervical cancer	0.00646	0.0105	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—CASP3—cervical cancer	0.00625	0.0101	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—CASP3—cervical cancer	0.00625	0.0101	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—CTNNB1—cervical cancer	0.00602	0.00974	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00584	0.00944	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—STAT3—cervical cancer	0.00581	0.0094	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—MTOR—cervical cancer	0.00547	0.00886	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.00543	0.00879	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—TAAR6—cervical cancer	0.00516	0.00835	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—CASP8—cervical cancer	0.00498	0.00806	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—CASP8—cervical cancer	0.00498	0.00806	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—CTNNB1—cervical cancer	0.00492	0.00797	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—TAAR6—cervical cancer	0.00491	0.00795	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—CASP3—cervical cancer	0.00489	0.00792	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP8—cervical cancer	0.00474	0.00767	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—TAAR6—cervical cancer	0.00469	0.00759	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—TAAR6—cervical cancer	0.00446	0.00722	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00443	0.00718	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.00443	0.00718	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—CASP8—cervical cancer	0.00441	0.00713	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.00434	0.00702	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—STAT3—cervical cancer	0.00429	0.00695	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—HES1—cervical cancer	0.0042	0.0068	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—CASP8—cervical cancer	0.00406	0.00657	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—MTOR—cervical cancer	0.0039	0.00631	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—CASP3—cervical cancer	0.00377	0.0061	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—CASP3—cervical cancer	0.00377	0.0061	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—WNT2—cervical cancer	0.00366	0.00592	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP3—cervical cancer	0.00359	0.0058	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—AKAP13—cervical cancer	0.00354	0.00573	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—STAT3—cervical cancer	0.00349	0.00564	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—WNT2—cervical cancer	0.00348	0.00563	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—cervical cancer	0.00346	0.0056	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—AKAP13—cervical cancer	0.00337	0.00545	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—CASP3—cervical cancer	0.00334	0.0054	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—AKAP13—cervical cancer	0.00321	0.0052	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—CASP8—cervical cancer	0.00317	0.00513	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—AKAP13—cervical cancer	0.00306	0.00495	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—cervical cancer	0.00301	0.00488	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP8—cervical cancer	0.0029	0.0047	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—TP53—cervical cancer	0.00279	0.00451	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—WNT5A—cervical cancer	0.00277	0.00449	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TAAR6—cervical cancer	0.00277	0.00448	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CASP3—cervical cancer	0.00273	0.00442	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—CASP8—cervical cancer	0.00272	0.00441	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—WNT5A—cervical cancer	0.00264	0.00427	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TAAR6—cervical cancer	0.00263	0.00426	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.00246	0.00398	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—CTNNB1—cervical cancer	0.00244	0.00395	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—TP53—cervical cancer	0.00242	0.00391	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—cervical cancer	0.0023	0.00372	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP3—cervical cancer	0.0022	0.00356	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00219	0.00354	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—WNT2—cervical cancer	0.00216	0.0035	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—STAT3—cervical cancer	0.00213	0.00344	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CTNNB1—cervical cancer	0.00212	0.00343	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00211	0.00341	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—EGFR—cervical cancer	0.00209	0.00338	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—CASP3—cervical cancer	0.00206	0.00333	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—WNT2—cervical cancer	0.00206	0.00333	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—AKAP13—cervical cancer	0.0019	0.00307	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.00186	0.00301	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—AKAP13—cervical cancer	0.00181	0.00292	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00179	0.0029	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TP53—cervical cancer	0.00175	0.00284	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—HES1—cervical cancer	0.00167	0.0027	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—WNT5A—cervical cancer	0.00164	0.00265	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—EGFR—cervical cancer	0.00157	0.00255	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—WNT5A—cervical cancer	0.00156	0.00252	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.00142	0.0023	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—cervical cancer	0.00141	0.00228	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TP53—cervical cancer	0.00132	0.00214	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—NOTCH1—cervical cancer	0.00126	0.00204	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.00119	0.00193	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NOTCH2—cervical cancer	0.00115	0.00186	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NOTCH2—cervical cancer	0.00109	0.00177	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—HES1—cervical cancer	0.000943	0.00153	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TP53—cervical cancer	0.000928	0.0015	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—HES1—cervical cancer	0.000897	0.00145	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CTNNB1—cervical cancer	0.000838	0.00136	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TERT—cervical cancer	0.000826	0.00134	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TERT—cervical cancer	0.000786	0.00127	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGFR3—cervical cancer	0.000758	0.00123	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—STAT3—cervical cancer	0.00073	0.00118	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGFR3—cervical cancer	0.000721	0.00117	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NOTCH1—cervical cancer	0.000712	0.00115	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NOTCH1—cervical cancer	0.000677	0.0011	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—EGFR—cervical cancer	0.000664	0.00107	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—EGFR—cervical cancer	0.000634	0.00103	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—EGFR—cervical cancer	0.000603	0.000976	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MTOR—cervical cancer	0.000533	0.000863	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MTOR—cervical cancer	0.000507	0.000821	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CASP3—cervical cancer	0.000491	0.000794	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CTNNB1—cervical cancer	0.000473	0.000765	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CASP3—cervical cancer	0.000467	0.000755	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CTNNB1—cervical cancer	0.00045	0.000728	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—STAT3—cervical cancer	0.000412	0.000667	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—STAT3—cervical cancer	0.000392	0.000634	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—EGFR—cervical cancer	0.000375	0.000606	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—EGFR—cervical cancer	0.000356	0.000577	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TP53—cervical cancer	0.000315	0.000509	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TP53—cervical cancer	0.000299	0.000484	CbGpPWpGaD
